Xiaohong Peng

1.9k total citations · 1 hit paper
61 papers, 1.4k citations indexed

About

Xiaohong Peng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Xiaohong Peng has authored 61 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Cancer Research and 13 papers in Surgery. Recurrent topics in Xiaohong Peng's work include Head and Neck Cancer Studies (10 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (5 papers). Xiaohong Peng is often cited by papers focused on Head and Neck Cancer Studies (10 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (5 papers). Xiaohong Peng collaborates with scholars based in China, United States and Australia. Xiaohong Peng's co-authors include Xiong Liu, Juan Lü, Xiangping Li, Fan Wang, Jia-Jie Tan, Yaqin Zhang, Bao Zhang, Qihui Liu, Xia Xu and Xi Fang and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and The Journal of Immunology.

In The Last Decade

Xiaohong Peng

58 papers receiving 1.4k citations

Hit Papers

Trimethylamine N-oxide impairs β-cell function and glucos... 2024 2026 2025 2024 10 20 30 40

Peers

Xiaohong Peng
Lin Qiu China
Peng Gao China
Can Wang China
Hae‐Yun Jung South Korea
Yan Ru Su United States
Lin Qiu China
Xiaohong Peng
Citations per year, relative to Xiaohong Peng Xiaohong Peng (= 1×) peers Lin Qiu

Countries citing papers authored by Xiaohong Peng

Since Specialization
Citations

This map shows the geographic impact of Xiaohong Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohong Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohong Peng more than expected).

Fields of papers citing papers by Xiaohong Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohong Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohong Peng. The network helps show where Xiaohong Peng may publish in the future.

Co-authorship network of co-authors of Xiaohong Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohong Peng. A scholar is included among the top collaborators of Xiaohong Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohong Peng. Xiaohong Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xu, Xiankang, Xiaohong Peng, Bo Zheng, Junchao Zhu, & Ling Chen. (2024). Maltogenic amylase and glucosyltransferase synergistically control the chain structure of rice starch and their effects on rheological properties and functional characteristics of rice milk. Food Hydrocolloids. 160. 110842–110842. 6 indexed citations
3.
Zhao, Yun, Yi Hong, Xiaohong Peng, et al.. (2024). Protocol for scarless genome editing of human pluripotent stem cell based on orthogonal selective reporters. STAR Protocols. 5(2). 103084–103084. 1 indexed citations
4.
Kong, Lijuan, Xiaojing Jiang, Qian Jiang, et al.. (2024). Trimethylamine N-oxide impairs β-cell function and glucose tolerance. Nature Communications. 15(1). 2526–2526. 44 indexed citations breakdown →
5.
Chen, Yibing, Chunxiao Ma, Xiaohong Peng, et al.. (2024). Galectin-3 impairs calcium transients and β-cell function. Nature Communications. 15(1). 3682–3682. 15 indexed citations
6.
Ma, Bin, Yun Zhao, Liangliang Tian, et al.. (2024). Targeted Therapy of Osteoarthritis via Intra‐Articular Delivery of Lipid‐Nanoparticle‐Encapsulated Recombinant Human FGF18 mRNA. Advanced Healthcare Materials. 13(29). e2400804–e2400804. 10 indexed citations
7.
Zhu, Wenjun, Min Fu, Qianxia Li, et al.. (2024). Amino acid metabolism-related genes as potential biomarkers and the role of MATN3 in stomach adenocarcinoma: A bioinformatics, mendelian randomization and experimental validation study. International Immunopharmacology. 143(Pt 1). 113253–113253. 3 indexed citations
8.
Yuan, Xiaofei, Junzheng Li, Zilu Chen, et al.. (2023). Systemic immune-inflammation index during treatment predicts prognosis and guides clinical treatment in patients with nasopharyngeal carcinoma. Journal of Cancer Research and Clinical Oncology. 149(1). 191–202. 9 indexed citations
9.
Qin, Han, et al.. (2023). Effects of Dexmedetomidine on Perioperative Brain Protection in Elderly Frail Patients. 2(3). 29–33. 4 indexed citations
10.
Yuan, Xiaofei, et al.. (2022). Effects of writers, erasers and readers within miRNA‐related m6A modification in cancers. Cell Proliferation. 56(1). e13340–e13340. 42 indexed citations
11.
Zhou, Xiaohan, Yanling Lin, Yuting Chen, et al.. (2021). Epstein–Barr virus (EBV) encoded microRNA BART8‐3p drives radioresistance‐associated metastasis in nasopharyngeal carcinoma. Journal of Cellular Physiology. 236(9). 6457–6471. 15 indexed citations
12.
Deng, Rui, Juan Lü, Xiong Liu, et al.. (2020). <p>PD-L1 Expression is Highly Associated with Tumor-Associated Macrophage Infiltration in Nasopharyngeal Carcinoma</p>. Cancer Management and Research. Volume 12. 11585–11596. 26 indexed citations
13.
Li, Yongyin, Libo Tang, Ling Guo, et al.. (2019). CXCL13-mediated recruitment of intrahepatic CXCR5+CD8+ T cells favors viral control in chronic HBV infection. Journal of Hepatology. 72(3). 420–430. 77 indexed citations
14.
Lü, Juan, Qihui Liu, Fan Wang, et al.. (2018). Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma. Journal of Experimental & Clinical Cancer Research. 37(1). 147–147. 176 indexed citations
15.
Tang, Huayuan, Hong Wang, Qingsong Lin, et al.. (2017). Loss of IP3 Receptor–Mediated Ca2+ Release in Mouse B Cells Results in Abnormal B Cell Development and Function. The Journal of Immunology. 199(2). 570–580. 29 indexed citations
16.
Peng, Xiaohong, et al.. (2017). Local Anesthetic Drug Inhibits Growth and Survival in Chronic Myeloid Leukemia Through Suppressing PI3K/Akt/mTOR. The American Journal of the Medical Sciences. 355(3). 266–273. 24 indexed citations
17.
Peng, Xiaohong, Feipeng Zhao, Xiong Liu, et al.. (2014). MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression. International Journal of Oncology. 44(4). 1215–1222. 44 indexed citations
18.
Yao, Anqi, You Wang, Xiaohong Peng, et al.. (2014). Predictive value of excision repair cross-complementation group 1 expression for platinum-based chemotherapy and survival in gastric cancer: a meta-analysis. Journal of Cancer Research and Clinical Oncology. 140(12). 2107–2117. 11 indexed citations
19.
Ren, Bin, et al.. (2013). Crystal Structure of Tannase from Lactobacillus plantarum. Journal of Molecular Biology. 425(15). 2737–2751. 55 indexed citations
20.
Xu, Hui, Wei He, Huangang Jiang, et al.. (2013). Prognostic value of mitochondrial DNA content and G10398A polymorphism in non-small cell lung cancer. Oncology Reports. 30(6). 3006–3012. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026